
Apotex Health Corp's stock has seen a notable decline this week, prompted by recent corporate developments.
This week, Apotex Health Corp (APTX.TO) experienced a drop in its stock price, closing down 2.02% on Wednesday. The decline follows the announcement of a successful secondary offering, which may have influenced investor sentiment.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
Market cap
$7.33B
52W high
$40.11
52W low
$26.01
1W change
-4.73%
Analyst Price Targets
Based on analyst covering APTX · as of Sep 23, 2026
Wall Street analysts forecast APTX stock price to rise 31.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.37
+31.5% Upside
Previously C$41.23 on Sep 17, 2026
Current Price
C$31.45
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
44.1%
Annualized
90-Day Vol
48.8%
Annualized
Trend (90d)
-32.1%
Annualized drift
90d Mean
C$28.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$30.27 | C$26.00 – C$35.24 |
| 60 trading days | C$29.13 | C$23.50 – C$36.12 |
| 90 trading days | C$28.04 | C$21.55 – C$36.49 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the implications of the recent secondary offering and the stock's performance relative to its moving averages and analyst outlook. While the stock is down this week, it has shown a positive year-to-date performance, indicating some resilience in the face of recent challenges.
Apotex Health Corp's stock down 4.73% this week.
With the stock currently at C$31.45, it is trading 9.5% below its 50-day moving average and 7.7% below its 200-day moving average.
Bull case
Analysts are optimistic about Apotex Health Corp, with an average target suggesting a potential upside of 31.5%, bringing the stock to C$41.37. This reflects a bullish outlook despite the current price pressures.
Bear case
The recent secondary offering might dilute existing shares, adding to the downward pressure on the stock. Furthermore, the stock's performance below its moving averages raises concerns about its near-term strength.
Recent Price Action
Advertisement
This week, Apotex Health Corp's stock has declined by 4.73%, with a notable drop of 2.02% on Wednesday. The stock closed at C$31.45, reflecting investor reactions to the company's recent developments.
Company News
On September 18, 2026, Apotex Health Corp announced the closing of an upsized bought deal secondary offering. This move is often seen as a method for companies to raise capital, but it can also lead to concerns regarding share dilution among existing investors.
Technical Picture
Apotex Health Corp is currently trading at C$31.45, which is 9.5% lower than its 50-day moving average of C$34.75 and 7.7% below its 200-day moving average of C$34.08. The stock has a 52-week range of C$26.01 to C$40.11, indicating it is currently at 39% of its range. The latest trading volume was 495,081 shares, which is about 67% of its 20-day average volume of 735,166 shares.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


